Location of Aldosterone-Producing Adenomas with131I-19-Iodocholesterol

Authors:
  • MHMichael J. Hogan
    Michael J. Hogan
  • JMJames McRae
    James McRae
  • MSMorris Schambelan
    Morris Schambelan
  • EBEdward G. Biglieri
    Edward G. Biglieri

Abstract
We used 131I-19-iodocholesterol as an adrenal-imaging agent in 27 hypertensive patients who had biochemical evidence of abnormalities in the renin–angiotensin–aldosterone system. In 10 of 12 patients in whom the biochemical findings suggested the presence of an aldosterone-producing adenoma the adrenal uptake was asymmetric. The adenoma was subsequently confirmed in all eight patients in this group who underwent operation. In contrast, the adrenal uptake was asymmetric in only one of 13 patients with biochemical evidence of idiopathic hyperaldosteronism or low-renin essential hypertension. Two patients with adrenal carcinoma causing primary aldosteronism did not concentrate the isotope in their tumors.

This publication has 19 references indexed in Scilit: